PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
PharmaCyte Biotech (PMCB) Ownership Overview
6.93% Insiders
1.39% Mutual Funds
1.37% Other Institutional Investors
0.48% ETFs
89.84% Public Companies and
Individual Investors
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail, and individual investors. Approximately 3.23% of the company’s stock is owned by Institutional Investors, 6.93% is owned by Insiders, and 89.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 07, 2026 | xxxxxxxxxxxxx | $80000 | |
Jan 07, 2026 | xxxxxxxxxxxxx | $48000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 466,250 | Insider | 4.34% | 336,633 | |
| 192,500 | Insider | 1.79% | 138,985 | |
| 95,525 | Institution | 0.89% | 68,969 | |
| 51,467 | Institution | 0.48% | 37,159 | |
| 51,467 | Institution | 0.48% | 37,159 | |
| 41,250 | Insider | 0.38% | 29,783 | |
| 23,092 | Insider | 0.22% | 16,672 | |
| 20,625 | Insider | 0.19% | 14,891 | |
| 1,804 | Institution | 0.02% | 1,302 | |
| 2 | Institution | <0.01% | 2 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 95,525 | Institution | 0.89% | 68,969 | |
| 51,467 | Institution | 0.48% | 37,159 | |
| 1,804 | Institution | 0.02% | 1,302 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 51,467 | Institution | 0.48% | 35,517 |
FAQ
Who Owns PharmaCyte Biotech (PMCB)?
According to the latest TipRanks data, approximately 1.37% of the company's stock is held by institutional investors, 6.93% is held by insiders, and 89.84% is held by retail investors.
What percentage of PharmaCyte Biotech (PMCB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.37% of PharmaCyte Biotech (PMCB) stock is held by institutional investors.
What percentage of PharmaCyte Biotech (PMCB) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.84% of PharmaCyte Biotech (PMCB) stock is held by retail investors.
Who owns the most shares of PharmaCyte Biotech (PMCB)?
Joshua Silverman owns the most shares of PharmaCyte Biotech (PMCB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.